Erratum: Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements (PLoS ONE (2014) 9, 3 (e90645) DOI:10.1371/journal.pone.0090645));Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Olson, Carl O ^a   Zachariah, Robby M ^a   Ezeonwuka, Chinelo D ^a   Liyanage, Vichithra R B ^a   Rastegar, Mojgan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; METHYL CPG BINDING PROTEIN 2; OLIGONUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN STEM; CELL TYPE; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC CORRELATION; HIPPOCAMPUS; MALE; MECP2 GENE; MOUSE; NONHUMAN; OLFACTORY BULB; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY SEQUENCE; TEMPORAL LOBE; THALAMUS;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SEQUENCE ANALYSIS, DNA;

EID: 84896991213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101030     Document Type: Erratum

References (76)

1. LaSalle JM, Yasui DH (2009) Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 1: 119-130.
2. Zachariah RM, Rastegar M (2012) Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast 2012: 415825.
3. Ezeonwuka C, Rastegar M (2014) MeCP2-Related Diseases and Animal Models. Diseases 2: 45-70.
4. Tunc-Ozcan E, Ullmann TM, Shukla PK, Redei EE (2013) Low-Dose Thyroxine Attenuates Autism-Associated Adverse Effects of Fetal Alcohol in Male Offspring's Social Behavior and Hippocampal Gene Expression. Alcohol Clin Exp Res.
5. Kim P, Park JH, Choi CS, Choi I, Joo SH, et al. (2013) Effects of Ethanol Exposure During Early Pregnancy in Hyperactive, Inattentive and Impulsive Behaviors and MeCP2 Expression in Rodent Offspring. Neurochem Res 38: 620-631.
6. Romano-Lopez A, Mendez-Diaz M, Ruiz-Contreras AE, Carrisoza R, Prospero-Garcia O (2012) Maternal separation and proclivity for ethanol intake: a potential role of the endocannabinoid system in rats. Neuroscience 223: 296-304.
7. Repunte-Canonigo V, Chen J, Lefebvre C, Kawamura T, Kreifeldt M, et al. (2013) MeCP2 regulates ethanol sensitivity and intake. Addict Biol.
8. Liyanage VRB, Zachariah RM, Delcuve GP, Davie JR, Rastegar M (2012) New Developments in Chromatin Research: An Epigenetic Perspective. In: Simpson NM, Stewart VJ, editors. New Developments in Chromatin Research: Nova Science Publishers pp. 29-58.
9. Delcuve GP, Rastegar M, Davie JR (2009) Epigenetic control. J Cell Physiol 219: 243-250.
10. Meehan RR, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085-5092.
11. Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N (2012) MeCP2 binds to 5 hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151: 1417-1430.
12. Cartron PF, Nadaradjane A, Lepape F, Lalier L, Gardie B, et al. (2013) Identification of TET1 Partners That Control Its DNA-Demethylating Function. Genes Cancer 4: 235-241.
13. Kriaucionis S, Bird A (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 32: 1818-1823. (Pubitemid 38832727)
14. Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36: 339-341. (Pubitemid 38437255)
15. Dastidar SG, Bardai FH, Ma C, Price V, Rawat V, et al. (2012) Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. J Neurosci 32: 2846-2855.
16. Itoh M, Tahimic CG, Ide S, Otsuki A, Sasaoka T, et al. (2012) Methyl CpG-binding protein isoform MeCP2-e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. J Biol Chem 287:13859-13867.
17. Liyanage VR, Zachariah RM, Rastegar M (2013) Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol Autism 4: 46.
18. Rastegar M, Hotta A, Pasceri P, Makarem M, Cheung AY, et al. (2009) MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One 4: e6810.
19. Cusack SM, Rohn TT, Medeck RJ, Irwin KM, Brown RJ, et al. (2004) Suppression of MeCP2β expression inhibits neurite extension in PC12 cells. Exp Cell Res 299: 442-453. (Pubitemid 39179810)
20. Dragich JM, Kim YH, Arnold AP, Schanen NC (2007) Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol 501: 526-542. (Pubitemid 46622494)
21. Zachariah RM, Olson CO, Ezeonwuka C, Rastegar M (2012) Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PLoS One 7: e49763.
22. Yasui DH, Gonzales ML, Aflatooni JO, Crary FK, Hu DJ, et al. (2014) Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet.
23. Saxena A, de Lagarde D, Leonard H, Williamson SL, Vasudevan V, et al. (2006) Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2. J Med Genet 43: 470-477. (Pubitemid 43927320)
24. Sheikh TI, Mittal K, Willis MJ, Vincent JB (2013) A synonymous change, p.Gly16Gly in MECP2 Exon 1, causes a cryptic splice event in a Rett syndrome patient. Orphanet J Rare Dis 8: 108.
25. Petel-Galil Y, Benteer B, Galil YP, Zeev BB, Greenbaum I, et al. (2006) Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J Med Genet 43: e56.
26. Jugloff DG, Vandamme K, Logan R, Visanji NP, Brotchie JM, et al. (2008) Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum Mol Genet 17: 1386-1396. (Pubitemid 351627335)
27. Liu J, Francke U (2006) Identification of cis-regulatory elements for MECP2 expression. Hum Mol Genet 15: 1769-1782. (Pubitemid 43821767)
28. Adachi M, Keefer EW, Jones FS (2005) A segment of the Mecp2 promoter is sufficient to drive expression in neurons. Hum Mol Genet 14: 3709-3722. (Pubitemid 41754670)
29. Singh J, Saxena A, Christodoulou J, Ravine D (2008) MECP2 genomic structure and function: insights from ENCODE. Nucleic Acids Res 36: 6035-6047.
30. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1: e1-11.
31. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, et al. (2008) MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1: 169-178.
32. Franklin TB, Russig H, Weiss IC, Graff J, Linder N, et al. (2010) Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry 68: 408-415.
33. Jung BP, Jugloff DG, Zhang G, Logan R, Brown S, et al. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 55: 86-96. (Pubitemid 36396964)
34. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115-124. (Pubitemid 34157003)
35. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326. (Pubitemid 32201856)
36. Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, et al. (2013) MeCP2 modulates gene expression pathways in astrocytes. Mol Autism 4: 3.
37. Ballas N, Lioy DT, Grunseich C, Mandel G (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12: 311-317.
38. Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, et al. (1993) Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 34: 227-234. (Pubitemid 23223052)
39. Subramaniam B, Naidu S, Reiss AL (1997) Neuroanatomy in Rett syndrome: cerebral cortex and posterior fossa. Neurology 48: 399-407. (Pubitemid 27087611)
40. Oldfors A, Sourander P, Armstrong DL, Percy AK, Witt-Engerstrom I, et al. (1990) Rett syndrome: cerebellar pathology. Pediatr Neurol 6: 310-314. (Pubitemid 20352041)
41. Ronnett GV, Leopold D, Cai X, Hoffbuhr KC, Moses L, et al. (2003) Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol 54: 206-218. (Pubitemid 36909619)
42. Armstrong DD (2005) Neuropathology of Rett syndrome. J Child Neurol 20: 747-753.
43. Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet 13: 629-639. (Pubitemid 38379852)
44. Wither RG, Lang M, Zhang L, Eubanks JH (2013) Regional MeCP2 expression levels in the female MeCP2-deficient mouse brain correlate with specific behavioral impairments. Exp Neurol 239: 49-59.
45. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, et al. (2008) Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59: 947-958.
46. Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, et al. (2006) Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 59: 468-476. (Pubitemid 43289228)
47. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27: 327-331. (Pubitemid 32201857)
48. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, et al. (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
49. Adachi M, Autry AE, Covington HE 3rd, Monteggia LM (2009) MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci 29: 4218-4227.
50. Wu SH, Camarena V (2009) MeCP2 function in the basolateral amygdala in Rett syndrome. J Neurosci 29: 9941-9942.
51. Na ES, Nelson ED, Adachi M, Autry AE, Mahgoub MA, et al. (2012) A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J Neurosci 32: 3109-3117.
52. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, et al. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484: 105-109.
53. Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 29: 5051-5061.
54. Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, et al. (2012) Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 7: e35354.
55. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, et al. (2011) A role for glia in the progression of Rett's syndrome. Nature 475: 497-500.
56. Vora P, Mina R, Namaka M, Frost EE (2010) A novel transcriptional regulator of myelin gene expression: implications for neurodevelopmental disorders. Neuroreport 21: 917-921.
57. Wu W, Gu W, Xu X, Shang S, Zhao Z (2012) Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome. Neurol Res 34: 107-113.
58. Alcobia I, Dilao R, Parreira L (2000) Spatial associations of centromeres in the nuclei of hematopoietic cells: evidence for cell-type-specific organizational patterns. Blood 95: 1608-1615. (Pubitemid 30120820)
59. Mayer R, Brero A, von Hase J, Schroeder T, Cremer T, et al. (2005) Common themes and cell type specific variations of higher order chromatin arrangements in the mouse. BMC Cell Biol 6: 44.
60. Taylor MM, Doshi S (2012) Insights into the cellular and molecular contributions of MeCP2 overexpression to disease pathophysiology. J Neurosci 32: 9451-9453.
61. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY (2009) Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 18: 2431-2442.
62. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, et al. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229. (Pubitemid 351929512)
63. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, et al. (2010) The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5: e8888.
64. Nestor C, Ruzov A, Meehan R, Dunican D (2010) Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48: 317-319.
65. Marin M, Karis A, Visser P, Grosveld F, Philipsen S (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 89: 619-628. (Pubitemid 27511772)
66. Furuta T, Shuto T, Shimasaki S, Ohira Y, Suico MA, et al. (2008) DNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription. BMC Mol Biol 9: 39.
67. Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, et al. (2003) Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 23: 4056-4065. (Pubitemid 36666412)
68. Filippova GN, Thienes CP, Penn BH, Cho DH, Hu YJ, et al. (2001) CTCFbinding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat Genet 28: 335-343. (Pubitemid 32702422)
69. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, et al. (2011) CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 479: 74-79.
70. Barber BA, Liyanage VR, Zachariah RM, Olson CO, Bailey MA, et al. (2013) Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells. Ann Anat.
71. Kobrossy L, Rastegar M, Featherstone M (2006) Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation. J Biol Chem 281: 25926-25939. (Pubitemid 44401798)
72. Nolte C, Rastegar M, Amores A, Bouchard M, Grote D, et al. (2006) Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis. Dev Biol 299: 582-593. (Pubitemid 44637278)
73. Rastegar M, Kobrossy L, Kovacs EN, Rambaldi I, Featherstone M (2004) Sequential histone modifications at Hoxd4 regulatory regions distinguish anterior from posterior embryonic compartments. Mol Cell Biol 24: 8090-8103. (Pubitemid 39167459)
74. Rastegar M, Rousseau GG, Lemaigre FP (2000) CCAAT/enhancer-binding protein-alpha is a component of the growth hormone-regulated network of liver transcription factors. Endocrinology 141: 1686-1692. (Pubitemid 32274397)
75. Wu CH, Rastegar M, Gordon J, Safa AR (2001) beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Oncogene 20: 7006-7020. (Pubitemid 33052193)
76. Gordon J, Wu CH, Rastegar M, Safa AR (2003) Beta2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species. Int J Cancer 103: 316-327. (Pubitemid 36076424)